Methods of stimulating angiogenesis in a patient by administering vascular endothelial growth factor 2
Patent Number: 7,186,688
Date of First Priority Issue: Tuesday March 8th, 1994
Date Issued: Tuesday March 6th, 2007
Assignee: Human Genome Sciences, Inc. (Rockville, MD)
Inventors: Hu; Jing-Shan (Sunnyvale, CA), Rosen; Craig A. (Laytonsville, MD), Cao; Liang (Hong Kong, CN)
From Class: Use
Comments: No comments
VEGF (vascular endothelial growth factor) is a potent endothelial cell mitogen that has previously been used in clinical trials for therapeutic angiogenesis. The current patent covers the use of specific fragments of VEGF for the stimulation of angiogenesis and the treatment of various conditions. Specific conditions for treatment include limb ischemia, cardiovascular disease and acceleration of wound healing.
View this patent on the USPTO website.
Added to StemCellPatents.com on Monday March 12th, 2007
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.